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High energy production in mitochondria is essential
for maintaining cardiac contraction in the heart.
Genes regulating mitochondrial function are com-
monly downregulated during heart failure. Here we
show that both PPARa and Sirt1 are upregulated by
pressure overload in the heart. Haploinsufficiency
of either PPARa or Sirt1 attenuated pressure over-
load-induced cardiac hypertrophy and failure,
whereas simultaneous upregulation of PPARa and
Sirt1 exacerbated the cardiac dysfunction. PPARa
and Sirt1 coordinately suppressed genes involved
in mitochondrial function that are regulated by
estrogen-related receptors (ERRs). PPARa bound
and recruited Sirt1 to the ERR response element
(ERRE), thereby suppressing ERR target genes
in an RXR-independent manner. Downregulation of
ERR target genes was also observed during fasting,
and this appeared to be an adaptive response of
the heart. These results suggest that suppression
of the ERR transcriptional pathway by PPARa/Sirt1,
a physiological fasting response, is involved in the
progression of heart failure by promoting mitochon-
drial dysfunction.
INTRODUCTION
Heart failure is a leading cause of death worldwide. The heart is
an organ with high energy production and consumption because
it must constantly pump blood against blood pressure. Cardiac
myocytes harbor a high volume of mitochondria, which play
a major role in mediating energy production in these cells.
Cardiac hypertrophy is induced by increased mechanical load
such as high blood pressure. Hypertrophic growth is initially
a compensatory response that helps maintain cardiac function
by reducing wall stress, but it eventually leads to the develop-
ment of heart failure. This progression is well demonstrated by
an experimental model, in which high blood pressure is induced
in the heart, termed transverse aortic constriction (TAC). The left598 Cell Metabolism 14, 598–611, November 2, 2011 ª2011 Elsevierventricle (LV) is subjected to high blood pressure by constriction
of the aorta, which provokes cardiac hypertrophy and then
heart failure. Heart failure represents a complex phenotype
that includes reduced myocardial contractility, increased myo-
cyte cell death, and myocardial fibrosis. During heart failure,
mitochondria display ultrastructural and bioenergetic defects,
which lead to insufficient energy production, increased oxidative
stress, and cell death (Russell et al., 2005). However, the
mechanism mediating these pathological changes in mitochon-
dria during the development of cardiac disease is not fully
understood.
Nuclear receptors form a superfamily of transcription factors
that orchestrate a wide range of biological functions, including
development, immune responses, cell growth, and metabolism
(Glass, 2006). DNA-binding sites of nuclear receptors, known
as hormone response elements (HREs), consist of a common
hexad sequence, such as AGGTCA or AGAACA, which can be
configured into direct repeats, inverted repeats, and everted
repeats (Mangelsdorf et al., 1995). In addition, the single hexad
sequence is recognized by several nuclear receptors, including
estrogen related receptors (ERRs) (Sladek et al., 1997).
ERRs consist of three different isoforms: ERR-a, -b, and -g.
ERRs are activated by transcription coactivators such as PGC-
1a and PGC-1b, crucial regulators of mitochondrial function
(Huss et al., 2002). The ERR response elements (ERREs), whose
consensus sequence is TNAAGGTCA (where N is any nucleo-
tide), are frequently found in the promoter regions of genes
regulating mitochondrial function, such as those encoding
components of the respiratory chain (Gigue`re, 2008). In addition,
ERRs directly regulate transcription of modulators of cardiac
contraction, namelyAtp2a2 andHrc, and important transcription
factors, including ERRa itself, PGC-1a, Jarid2, and Irx4, and,
therefore, ERRs are recognized as pleiotropic regulators of heart
function (Dufour et al., 2007; Wang et al., 2005). Gene disruption
of mouse ERRa causes heart failure with impaired mitochondrial
ATP production under pressure overload conditions (Huss et al.,
2007). Since downregulation of the PGC1a-ERRa axis and
consequent development of both mitochondrial and contractile
dysfunction are frequently observed in heart failure patients (Kar-
amanlidis et al., 2010; Sihag et al., 2009), impaired ERR target
gene expression is considered to be a hallmark of failing hearts.
Peroxisome proliferator-activated receptors (PPARs), com-
prising PPARa, -b/d, and -g, belong to the nuclear receptorInc.
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(RXRs) and bind to a response element called direct repeat 1
(DR1) or PPAR response element (PPRE), whose consensus
sequence is AGGTCANAGGTCA (Schoonjans et al., 1996),
with PPAR and RXR occupying the 50 and 30 AGGTCA se-
quences, respectively. PPARa is activated by fatty acid ligands
to induce expression of genes promoting fatty acid uptake and
oxidation, whereas PPARg is an important regulator of adipo-
genesis and fat storage (Spiegelman, 1998). In the heart, artificial
ligands for PPARa, such as fenofibrate, protect against endothe-
lin-induced cardiac hypertrophy and failure (Irukayama-Tomobe
et al., 2004), and cardiac function is severely damaged in PPARa
null mice during pressure overload (Smeets et al., 2008).
Cardiac-specific overexpression of PPARa also results in hyper-
trophy and failure in association with intracellular accumulation
of neutral lipids, termed lipotoxicity (Finck et al., 2002). Thus,
PPARa both positively and negatively regulates cardiac function.
The molecular mechanism through which PPARa exerts dichot-
omic effects on the heart remains to be elucidated.
Silent information regulator 1 (Sirt1) plays an important role in
gene silencing and life span extension under starvation condi-
tions (Bordone and Guarente, 2005). Cellular responses to
nutrient starvation, including metabolic adaptation to fasting,
are mediated by Sirt1 through its protein-protein interaction
with and posttranslational modification of PGC-1a and PPAR
(Rodgers et al., 2008). However, Sirt1-mediated regulation of
PPAR is complex. For example, fatty acid mobilization from
adipose tissues is enhanced by Sirt1 through inhibition of PPARg
(Picard et al., 2004), whereas Sirt1 activates PPARa to promote
fatty acid oxidation in the liver (Purushotham et al., 2009).
We here demonstrate that PPARa negatively regulates ex-
pression of genes involved in mitochondrial respiration and
cardiac contraction through direct interactionwith a single hexad
motif of HREs, such as ERRE, in the heart under pressure over-
load. The negative regulation of a single hexad motif of HREs
by PPARa takes place independently of RXR but in a Sirt1-
dependent manner in the heart in response to pressure overload,
as well as under physiological fasting conditions. These results
suggest that binding of PPARa/Sirt1 to the single hexad motif
of HREs plays an important role in mediating downregulation of
the ERR target genes, which in turn promotes heart
failure. Although this mechanism could mediate physiological
adaptation of the heart in response to starvation, inappropriate
activation of the samemechanism could lead to impaired energy
production and contractility, thereby facilitating progression of
heart failure during pressure overload, when the heart requires
highenergy tomaintain contraction against anelevatedafterload.
RESULTS
PPARa and Sirt1 Mediate Pressure Overload-Induced
Cardiac Hypertrophy
The level of Sirt1 in the nuclear fraction of the heart was upregu-
lated in response to pressure overload imposed by transverse
aortic constriction (TAC), consistent with our previous report
(Alcendor et al., 2007). TAC also upregulated PPARa (Figure 1A)
with activation of luciferase reporter gene driven by three repeats
of the PPAR response element in vivo (Tg-PPRE-luc) (Fig-
ure S1A). PPARa interacts with Sirt1 in cardiac myocytes (Fig-Cell Mure 1B). Haploinsufficiency of either PPARa (PPARa+/) or Sirt1
(Sirt1+/) attenuated cardiac hypertrophy after 4 weeks, but not
2 weeks, of TAC, as characterized by heart weight/body weight
(Figure 1C), heart weight/tibia length (Figures S1B and S1C), and
myocyte size (Figure 1D). Echocardiographic analyses showed
that TAC-induced systolic dysfunction, characterized by a
decreased ejection fraction, was prevented in PPARa+/ and
Sirt1+/ mice (Figure 1E). Thus, PPARa and Sirt1 play an impor-
tant role in mediating TAC-induced cardiac hypertrophy and
failure. Transgenic mice with cardiac-specific PPARa overex-
pression (Tg-PPARa) show moderate cardiomyopathy charac-
terized by hypertrophy and systolic dysfunction. However, the
PPARa-induced cardiac hypertrophy was ameliorated by down-
regulation of Sirt1 (Tg-PPARa/Sirt1+/) (Figures 1F and S1D),
suggesting that endogenous Sirt1 is required for the cardiac
hypertrophy observed in the Tg-PPARa. Taken together, these
results indicate that PPARa and Sirt1, in concert, facilitate pres-
sure overload-induced cardiac dysfunction and hypertrophy.
Since both PPARa and Sirt1 were upregulated in the heart under
pressure overload conditions, in order to test whether simulta-
neous upregulation of PPARa and Sirt1 is sufficient for mediating
cardiac hypertrophy, we crossed two lines each of Tg-Sirt1 and
Tg-PPARa to generate bigenic mice overexpressing both
PPARa and Sirt1 (Figure S1E). The PPARa transgene was
FLAG-tagged (Finck et al., 2002) and bound to both endogenous
and exogenous Sirt1 in the heart (Figure S1F). We did not detect
any acetylation of PPARa even in Tg-PPARa with a Sirt1/
background (Figure S1G). As shown previously, mild cardiac
hypertrophy was observed in Tg-PPARa. However, cardiac
hypertrophy was more severe in the Tg-PPARa/Tg-Sirt1 bigenic
mice (Figures 1G, 1H, and S1H). Lung congestion was more
prominent in the Tg-PPARa/Tg-Sirt1 bigenic mice (Figure S1I).
Systolic function was impaired in the Tg-PPARa/Tg-Sirt1 bigenic
mice, as evidenced by a decreased ejection fraction and frac-
tional shortening (Figure 1I and Table S1). These results suggest
that co-upregulation of Sirt1 and PPARa is sufficient to induce
cardiac hypertrophy and failure, even without pressure overload.
Sirt1 Attenuates PPARa-Induced Lipotoxicity
Sirt1 has been reported to activate PPARa (Purushotham et al.,
2009). The cardiomyopathic phenotype in the Tg-PPARa/
Tg-Sirt1 bigenic mice could be due to enhancement of PPARa-
mediated transcriptional activation by Sirt1. To test this hypoth-
esis, expression levels of PPARa target genes were evaluated.
As expected, known target genes of PPARa, such as Acox1,
CptIb, Cd36, and Pdk4, were upregulated in Tg-PPARa.
However, expression of those genes was not significantly
changed in the Tg-PPARa/Tg-Sirt1 bigenic mice compared to
in Tg-PPARa (Figure 2A). To elucidate the effect of Sirt1 on
PPARa-induced PPRE activation in vivo, the Tg-PPRE-luc
mice were crossed with Tg-PPARa and Tg-Sirt1. As shown
in Figure 2B, PPARa-induced activation of the PPRE-luc
activity was not significantly altered in the Tg-PPARa/Tg-Sirt1
bigenic mice. Furthermore, Sirt1 overexpression did not
affect PPRE-luc activity induced by fasting, a physiological
stimulus of PPARa. Thus, overexpression of Sirt1 does not
affect PPARa-induced PPRE activation in the heart. Microarray
analyses demonstrated that a subset of the PPAR target genes
was upregulated, while the rest of the target genes were eitheretabolism 14, 598–611, November 2, 2011 ª2011 Elsevier Inc. 599
Figure 1. PPARa and Sirt1 Are Involved in Pressure Overload (PO)-Induced Cardiac Hypertrophy
(A) PO induces co-upregulation of PPARa and Sirt1. Nuclear fractions were prepared from wild-type mice subjected to transverse aortic constriction (TAC)
for 4 weeks. Anti-histone H3 and tubulin antibodies were used to show nuclear and cytosolic fractions, respectively.
(B) Sirt1 was coimmunoprecipitated with PPARa from primary cultured cardiac myocytes. Open asterisk represents IgG.
(C–E) Haploinsufficiency of PPARa and Sirt1 attenuates PO-induced cardiac hypertrophy (C and D) and systolic dysfunction (E). PPARa+/ and Sirt1+/ mice
were subjected to 2 or 4 weeks of TAC. (C) The heart weight/body weight ratio was measured. Heart lysates were subjected to western blot analyses with anti-
PPARa and anti-Sirt1 antibodies. (D) After 4 weeks of TAC, cell size was measured using WGA staining. Representative images are shown. (E) After 4 weeks of
TAC, ejection fraction was measured by echocardiography.
(F) Haploinsufficiency of Sirt1 normalizes PPARa-induced cardiac hypertrophy.
(G and H) Co-overexpression of PPARa and Sirt1 induces cardiac hypertrophy. Heart weight/body weight ratio and myocytes cell size were measured.
(I) Ventricular dysfunction in Tg-PPARa/Tg-Sirt1 bigenic mice was evaluated by echocardiographic measurements. Representative M-mode echocardiographic
images of the left ventricle and ejection fraction are shown. The numbers of mice examined in each experimental group were: 4–12 (C), 3–8(D), 6–14 (E), 3–6 (F),
9–21 (G), 3 (H), and 7–19 (I). Error bars represent SEM.
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Thus, the effect of Sirt1 on PPARa-induced target gene expres-
sion was nonuniform in terms of directionality, rather than exhib-600 Cell Metabolism 14, 598–611, November 2, 2011 ª2011 Elsevieriting simple enhancement, a result which does not support the
involvement of PPRE-regulated genes in the cardiomyopathic
phenotype observed in the Tg-PPARa/Tg-Sirt1 bigenic mice.Inc.
Figure 2. The Effect of Sirt1 on PPARa Activity
(A) Relative mRNA expression of PPARa target genes in
transgenic mice.
(B) The effect of Sirt1 and PPARa on PPRE-luciferase
reporter activity in vivo. Tg-PPRE-luc mice were crossed
with Tg-PPARa, Tg-Sirt1, Tg-PPARa/Tg-Sirt1 or control
mice (left). Mice were subjected to 24 hr of fasting (right).
Luciferase assays were performed using heart lysates
prepared from these mice.
(C) A heat map of known PPARa target genes that were
upregulated in Tg-PPARa in microarray analyses. Gray
indicates undetectable expression.
(D and E) PPARa-induced neutral lipid accumulation was
attenuated by Sirt1. Oil red O staining (D) and triglyc-
eride quantification (E) were conducted in each mouse
genotype.
(F) PPARa-induced increases in H2O2 were attenuated
by Sirt1. The numbers of mice examined in each experi-
mental group were: 4–8 (A), 4–7 (B), 4–5 (E), and 6–9 (F).
Error bars represent SEM.
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is thought to be a major cause of PPARa-induced cardiomyop-
athy (Finck et al., 2002), PPARa-induced triglyceride accumu-
lation was actually suppressed by Sirt1 (Figures 2D and 2E).
Lipotoxicity is frequently accompanied by increased oxidative
stress. PPARa-induced increases in H2O2 were significantly
attenuated in the presence of Sirt1 (Figure 2F). Thus, Sirt1-
induced exacerbation of PPARa-induced cardiomyopathy in
the Tg-PPARa/Tg-Sirt1 bigenic mice is not due to the enhance-
ment of lipotoxicity.
The Target Genes of the Estrogen-Related Receptor
(ERR) Are Downregulated in Tg-Sirt1/Tg-PPARa
Bigenic Mice
Despite the varied effects of Sirt1 on expression of PPARa target
genes, surprisingly, microarray analyses revealed that PPARa
and Sirt1 cooperatively downregulated expression of many, ifCell Metabolism 14, 598not all, known and predicted target genes of
ERRs (Figure 3A). Although a subset of the
known ERR target genes, such as Mttp and
Acox1, was not suppressed but rather upregu-
lated, those genes are also known to be direct
targets of PPARa. Furthermore, genes reported
to be upregulated in ERRa knockout mice,
such as myosin light chains (Dufour et al.,
2007), were upregulated in Tg-PPARa/Tg-Sirt1
bigenic mice, indicating that the bigenic mice
have impaired ERR function. The expression
level of representative ERR target genes regu-
lating mitochondrial energy metabolism (Fig-
ure 3B), cardiac contraction (Figure 3C), and
transcription (Figure 3D) was further assessed
by quantitative PCR. Overall, these ERR target
genes were downregulated in Tg-PPARa and
in Tg-Sirt1, and they were further downregu-
lated in the Tg-PPARa/Tg-Sirt1 bigenic mice.
These results suggest that expression of ERR
target genes was coordinately downregulatedby PPARa and Sirt1 in the heart. We also examined the expres-
sion levels of ERRs and PGC-1s, since ERRa and PGC-1a are
reported to be ERR target genes (Dufour et al., 2007; Wang
et al., 2005). These genes were downregulated in Tg-PPARa/
Tg-Sirt1 bigenic mice, except for ERRg (Figure 3E).
Mitochondria in the hearts of the Tg-PPARa/Tg-Sirt1 bigenic
mice exhibited structural abnormalities, such as reduced
cristae density (Figures 4A and 4B), but normal mitochondrial
volume (Figure 4C). In addition, ATP production was impaired
in mitochondria isolated from the Tg-PPARa/Tg-Sirt1 bigenic
mice (Figure 4D). Notably, downregulation of ERR target
genes regulating myocardial contraction coincided with systolic
dysfunction in Tg-PPARa/Tg-Sirt1 bigenic mice (Figure 1I).
Taken together, these results suggest that downregulation
of the ERR target genes is well correlated with the functional
defects in both mitochondria and contractility in the Tg-
PPARa/Tg-Sirt1 bigenic mice.–611, November 2, 2011 ª2011 Elsevier Inc. 601
Figure 3. Gene Expression Profiles of ERR Target
Genes in Transgenic Mice
(A) A heat map representing the expression profile of ERR
target genes in transgenic mice. Known PPAR target
genes are indicated by cross mark.
(B–E) Relative gene expression levels of ERR target genes
regulating (B) mitochondrial metabolism, (C) contractile
work, (D) transcription factors, and (E) PGC-1 and ERR
isoforms in the indicated transgenic animals are shown
(N = 8–16). Error bars represent SEM.
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Expression
Since the ERRE contains a whole binding sequence of PPARa
as a monomeric unit (AGGTCA) (Figure 5A), we hypothesized
that PPARa suppresses gene expression through direct interac-
tion with the ERRE. To investigate whether PPARa binds to
the ERRE, double-stranded DNA pull-down assays were per-
formed with biotin-labeled double-stranded DNA (Figure 5B)
and bacterially expressed recombinant PPARa. As shown in
Figure 5C and Figure S2A, PPARa was pulled down with
biotin-labeled double-stranded DNA comprising a PPRE, three
repeats of ERRE with a 4 bp spacer (33ERRE) or a single
ERRE (13ERRE), but not with that comprising a 33ERREmutant
(03ERRE). The interaction between PPARa and biotin-labeled
13 and 33ERRE was competitively inhibited by biotin-free
double-stranded DNA containing ERRE(s), but not by that with
the ERRE mutant(s), suggesting that PPARa directly binds to
the ERRE in a sequence-specific manner. In heart lysates602 Cell Metabolism 14, 598–611, November 2, 2011 ª2011 Elsevier Inc.prepared from Tg-PPARa, PPARa was pulled
down with biotin-labeled 13 and 33ERRE.
The interaction between PPARa and 33ERRE
was competitively inhibited by biotin-free
13ERRE (Figures 5D and S2B). Thus, PPARa
is able to bind to a single hexad motif within
the ERRE. As shown in Figure 5E and Fig-
ure S2C, Sirt1 was pulled down with an oligonu-
cleotide containing a PPRE, as well as with one
containing ERREs, more effectively from Tg-
PPARa heart lysates than from nontransgenic
heart lysates, suggesting that PPARa recruits
Sirt1 to both the PPRE and the ERRE. The
amount of RXR pulled down with the ERRE
was less than that with the PPRE, suggesting
that PPARa and RXR form a dimer more
effectively on the PPRE than on the ERRE.
ERRa was pulled down with a biotin-labeled
ERRE, but the interaction was competitively
inhibited in the presence of PPARa, indicat-
ing that PPARa and ERRa compete for
the common DNA-binding site (Figure 5E).
Endogenous PPARa was recovered with
biotin-labeled 33ERRE more effectively from
the heart lysate prepared after 4 weeks of
TAC than from the control heart lysate (Figures
5F and S2D). Recombinant PPARa bound
to ERREs even in the presence of 20- and 60-
fold excesses of nonbiotin labeled polydeoxy(Inosinate-Cytidylate) acid as a nonspecific competitor (Fig-
ure S2E). To examine whether PPARa binds to the AGGTCA
motif in vivo, chromatin immunoprecipitation (ChIP) assays
were performed. As expected, genomic flanking regions of the
PPRE, such as those in the promoter regions of Acox1 and
PGC-1a (2168 to 2044), were significantly precipitated
with anti-FLAG antibody when FLAG-tagged PPARa was
expressed in the hearts of Tg-PPARa and Tg-PPARa/Tg-Sirt1
bigenic mice (Figure 5G). FLAG-tagged PPARa also bound
to flanking regions of single AGGTCA motifs, which are not
configured as a typical PPRE but are found either within an
ERRE or as an isolated AGGTCA motif, such as those in the
promoter regions of Sdha, PGC-1a (3348 to 3249), and
Atp2a2 (Figure 5G). Increased expression of PPARa resulted in
increased DNA binding of both PPARa and Sirt1 on flanking
regions of the single hexad motif in the promoter regions of
PPARa/Sirt1 suppressed genes (Figure 5H). There was no
typical PPRE located within the 1 kb flanking region of all
Figure 4. Mitochondrial Function Was Impaired in
Tg-PPARa/Tg-Sirt1 Bigenic Mice
(A) Electronmicroscopic analysis of the heart in transgenic
mice.
(B) Quantitative morphometric analyses of cardiac mito-
chondrial ultrastructural abnormalities.
(C) Mitochondrial volume of the transgenic mice.
(D) ATP synthesis in cardiac mitochondria isolated from
the transgenic mice (N = 7–10). Error bars represent SEM.
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and PGC1a (Figure 5G), suggesting that PPARa recruits Sirt1
to the single hexad motif in the heart. The downregulation of
the ERR target genes observed in Tg-PPARa was partially
normalized by haploinsufficiency of Sirt1 (Figure 5I). Thus, Sirt1
recruited by PPARa negatively regulates gene expression
directed by the single hexad motif.
PPARa Suppresses the ERRE in a Sirt1-Dependent
and RXR-Independent Manner
To investigate whether PPARa and Sirt1 suppress promoter
activity through interaction with the ERRE, reporter gene assays
were performed in cultured myocytes. As shown in Figure 6A,
PPARa and Sirt1 cooperatively suppressed reporter activity
driven by the promoter region of Ndufv1 containing three hexad
motifs. The 3.5 kb to 0.35 kb promoter region of PGC1a
also contains multiple common hexad motifs. PPARa and Sirt1
cooperatively suppressed reporter activity driven by a 3.5 kb,
but not by a 0.35 kb, promoter region. The PGC-1a promoter
contains a typical PPRE. PPARamay displace the other PPARs,
preventing them from binding to the PPRE and thereby
suppressing the promoter activity. However, PPARa and Sirt1
cooperatively suppressed reporter gene activity driven by the
PGC-1a promoter with a PPRE mutation. Thus, the PPRE is
not required for PPARa/Sirt1-mediated suppression of PGC-1a
promoter activity. PPARa and Sirt1 also suppressed reporterCell Metabolism 14, 598activity driven by three repeats of the ERRE
connected to the thymidine kinase promoter,
whereas VP16-ERRa, a transcriptional activa-
tion domain fused to ERRa, normalized both
the reporter gene activity and ERR target
gene expression, which were suppressed by
PPARa/Sirt1 in cultured myocytes (Figures 6B
and S3A). However, coexpression of PPARa
and Sirt1 did not effectively suppress, and
VP16-ERRa failed to activate, the reporter
activity when the ERRE sequences were
mutated (Figure 6B). Thus, the single hexad
motif of HREs, including that in the ERRE, plays
an essential role in mediating transcriptional
suppression by PPARa and Sirt1. PPARa-
mediated suppression of ERRE-reporter activity
was attenuated by knockdown of Sirt1 (Fig-
ure 6C), suggesting that endogenous Sirt1 is
a crucial partner for the PPARa-mediated
suppression of the ERRE.
PPARa-induced PPRE activation may con-
tribute to the suppression of the ERRE throughrecruitment of transcription activation machinery from the
ERRE to the PPRE, termed squelching. To test this possibility,
we examined the effect of a PPARamutant (PPARaDAF2), which
cannot bind to the coactivators, on ERRE-reporter gene
activity. The PPARa mutant retained the ability to bind to Sirt1
and suppressed ERRE reporter gene activity in the presence
of Sirt1 (Figure 6D). Thus, PPARa-mediated squelching is not
required for the ERRE suppression.
Since PGC-1a and PGC-1b activate ERRs, downregulation
of PGC-1s (Figure 3E) may be a major mechanism for PPARa/
Sirt1-induced downregulation of ERR target genes. However,
suppression of ERRE, Ndufv1, and PGC-1a reporter genes by
PPARa/Sirt1 was observed even in the presence of PGC-1a
overexpression (Figures 6E and S3B). Furthermore, overexpres-
sion of PGC-1a failed to normalize ERR target gene suppression
by PPARa/Sirt1 (Figure S3C). Thus, downregulation of PGC1a
is not essential for PPARa/Sirt1-mediated ERRE suppression.
RXRs play an important role in mediating DNA binding and
transcriptional activation of PPARa through the PPRE. However,
an isolated single hexad motif, such as that in the ERRE, would
not provide a binding site for RXR. Therefore, we investigated
the role of RXR in mediating the function of PPARa and Sirt1
at the ERRE. To examine the role of RXR in the interaction
between PPARa and Sirt1, immunodeprivation of RXRs was
performed with an anti-RXR antibody recognizing all RXR
isoforms. Sirt1 was coprecipitated with FLAG-PPARa after–611, November 2, 2011 ª2011 Elsevier Inc. 603
Figure 5. PPARa Binds to the Single Hexad Motif within the ERRE
(A) Schematic representation of topology of PPAR and RXR on the PPRE, and comparison of the PPRE and the ERRE.
(B–E) Recombinant PPARa (C) and PPARa in Tg-PPARa heart lysate (D–E) binds to both the PPRE and the ERRE. PPARa was pulled down using biotin-labeled
double-stranded DNA with the indicated sequences (B). Nonbiotin labeled competitors (1- to 10-fold of biotin-labeled DNA) are shown in blue (C–D).
(F) Endogenous PPARa was pulled down with 33ERRE after 4 weeks of TAC.
(G) PPARa binds to the single hexad motif in the heart. ChIP assays were performed with homogenates from Tg-PPARa and Tg-PPARa/Tg-Sirt1 hearts and
anti-FLAG antibody. Target single hexad motifs are shown in red (AGGTCA and AGGACA) and blue (one nucleotide redundancy in the last three letters from
AGGTCA or AGGACA) with proximal 7 bp sequences. Genomic regions amplified by quantitative PCR are indicated by nucleotide number from first codon under
target genes (N = 6–12).
(H) PPARa recruits Sirt1 to the flanking region of the single hexad motif. ChIP assays were performed in Tg-PPARa hearts using anti-PPARa and anti-Sirt1
antibodies (N = 8).
(I) Sirt1 recruited by PPARa suppresses gene expression. Quantitative PCR was performed using cDNA prepared from the indicated transgenic mice (N = 5–20).
Error bars represent SEM.
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for interaction between PPARa and Sirt1 in the heart (Figure 6F).
To assess the role of RXR in PPARa/Sirt1-mediated ERRE
suppression, we examined the effects of RXRa and an RXRa
mutant lacking the N-terminal DNA-binding domain, RXRa(DN),
on ERRE reporter activity. Although PPARa-induced PPRE
activation was significantly suppressed by RXRa(DN), PPARa/
Sirt1-mediated ERRE suppression was not affected (Figure 6G).
Furthermore, although RXRa significantly enhanced PPRE re-
porter activity in the presence of PPARa, it did not affect
PPARa/Sirt1-mediated ERRE suppression (Figure 6H). These
results suggest that RXR is a crucial factor for PPARa-induced
PPRE activation, but not for PPARa/Sirt1-mediated ERRE
suppression (Figure 6M, left).
Since PPRE/DR1 contains the single hexad motif (Figure 5A),
the PPARa/Sirt1 complex may suppress transcription under
circumstances where the level of RXRs is insufficient on the
PPRE/DR1. To test this hypothesis, we introduced different
doses of the PPRE reporter genes, together with PPARa and
Sirt1, into myocytes. PPARa-induced luminescence increased
sharply in response to increased amounts of the PPRE reporter
gene in the low dosage range, but became saturated in the
high dosage range. The saturated reporter activity was aug-
mented, however, by overexpression of RXRa, suggesting that
the amount of endogenous RXRs forming dimers with exoge-
nous PPARa on the PPRE is limited (Figure 6I). PPARa-induced
PPRE activation was not significantly changed by overexpres-
sion of Sirt1 when a smaller amount of PPRE reporter plasmid
was introduced, but Sirt1 suppressed the reporter activity
when a higher amount of PPRE reporter was cotransfected
into the cells (Figure 6J). The PPARa-induced PPRE reporter
activation was enhanced by knocking down Sirt1 (Figure 6K),
suggesting that activation of the PPRE reporter gene by PPARa
may be determined by the balance between PPARa/RXR-
mediated transcriptional activation and PPARa/Sirt1-mediated
transcriptional suppression when a high level of PPRE reporter
is used. PPARa/Sirt1-mediated PPRE suppressionwas reversed
by overexpression of RXRa (Figure 6L). These results suggest
that PPARa/Sirt1 suppresses transcription at the PPRE when
RXRs are insufficient to cover the other side of the half-core
site of PPRE (Figure 6M, right). Thus, PPARa facilitates both
activation of the PPRE and suppression of the single hexad
motif, as in the ERRE, with RXR and Sirt1, respectively.
PPARa and Sirt1 Suppress ERR Target Gene Expression
during Pressure Overload in the Heart
To examine whether PPARa and Sirt1-mediated gene suppres-
sion takes place in the heart subjected to pressure overload,
ChIP assays were performed. Binding of PPARa and Sirt1 to
the flanking region of the single hexad motif was significantly
increased after TAC in the promoters of Shda, PGC-1a, and
Apt2a2 after 2 weeks (Figure S4A) and 4 weeks of TAC (Fig-
ure 7A). The level of histone H3 acetylation at lysine 9, which is
deacetylated by Sirt1, was decreased in the promoter regions
of the ERR target genes after TAC. The occupancy of ERRa on
the ERREs was decreased by pressure overload (Figure 7B)
and by overexpression of PPARa (Figure S4B). On the other
hand, knocking down ERRa did not affect ERRE reporter gene
activity or recruitment of PPARa to the ERRE in cultured cardiacCell Mmyocytes (Figures S4C–S4E), despite the fact that the occu-
pancy of ERRa on the flanking region of ERREs was significantly
reduced (Figure S4F) and that expression of several ERR target
genes was significantly attenuated by downregulation of
ERRa (Figure S4G). Thus, downregulation of ERRa is not suffi-
cient to induce PPARa/Sirt1-mediated ERRE suppression.
TAC-induced downregulation of the ERR target genes was
attenuated in PPARa+/ and Sirt1+/ mice (Figures 7C and
S4H). Thus, endogenous PPARa and Sirt1 are both involved in
the suppression of the ERR target genes in the heart during pres-
sure overload.
PPARa/Sirt1-Induced Suppression of ERR Target Gene
Expression Is Adaptive during Fasting
In the last part of the study, a physiological role for the gene
suppression through PPARa and Sirt1 interaction was investi-
gated. Since both PPARa and Sirt1 are crucial factors that
mediate fasting responses, we hypothesized that PPARa/Sirt1-
mediated ERR suppression is a fasting response. To test this
hypothesis, PPARa+/ and Sirt1+/ mice were subjected to
fasting for 24 hr. As shown in Figure 7D, although typical PPAR
target genes, including Cd36 and Fabp4, were upregulated
following fasting in wild-typemice, their expression was reduced
in PPARa+/mice. ERR target genes, such as Sdha, Atp2a2, and
PGC1a were downregulated in wild-type mice following fasting,
but this downregulation was partly prevented in PPARa+/mice,
suggesting that PPARa mediates both PPRE activation and
ERRE suppression during fasting. The fasting-induced downre-
gulation of ERR target genes was partly normalized in Sirt1+/
mice. Thus, Sirt1 is required for suppression of ERR target genes
during starvation in the heart. Increased NAD+ and decreased
NADH levels were observed in the heart following both fasting
and TAC, conditions known to effectively promote Sirt1 activa-
tion due to an increased NAD/NADH ratio (Figure 7E).
To investigate the role of PPARa and Sirt1 in the heart under
fasting, cardiac function was assessed. Cardiac systolic func-
tion, such as ejection fraction, was slightly decreased in wild-
type mice after fasting, but not in either PPARa+/ or Sirt1+/
mice (Figure 7F). Using an isolated working mouse heart model,
under nutrient-free conditions, spontaneous beating terminated
earlier in hearts isolated from PPARa+/ and Sirt1+/mice than in
hearts from wild-type mice, suggesting that PPARa and Sirt1
play an important role in maintaining beating of the heart under
starvation conditions (Figure 7G). After 72 hr of incubation with
a glucose-free medium, the survival rate was decreased in
control cultured myocytes, but was improved by exogenous
PPARa. This protective effect was attenuated by knockdown
of Sirt1, suggesting that Sirt1 is required for the PPARa-medi-
ated prolongation of myocyte survival under starvation condi-
tions (Figure 7H). These results suggest that ERRE suppression
by the PPARa/Sirt1 is a fasting response to prolong cardiac
working time and cell survival under starvation conditions
through reduction of mitochondrial and systolic outputs. This
is in contrast to the condition of pressure overload, where the
heart cannot afford to slow down because of the need to main-
tain cardiac output against increased afterload. Thus, ERRE
suppression by the PPARa/Sirt1 complex is induced by both
pressure overload and fasting, but the advantageousness of its
function is context-dependent.etabolism 14, 598–611, November 2, 2011 ª2011 Elsevier Inc. 605
Figure 6. The Role of RXR in PPARa/Sirt1-Mediated ERRE Suppression
(A and B) PPARa and Sirt1 cooperatively suppress ERR target gene promoters (A). The ERRE is an important interface for PPARa/Sirt1-mediated
gene suppression (B). Schematic representations of each promoter are shown in these panels. The common hexad motifs of HREs are indicated by a
red line (AGGTCA and AGGACA), blue line (one nucleotide redundancy in the last three letters from AGGTCA or AGGACA) or black line (ERRE mutant:
TCGGAATCA).
(C) Sirt1 is a crucial partner for PPARa-induced ERRE suppression.
(D) Transcriptional activation of PPARa is not essential for ERRE suppression. Schematic representation of PPARa and PPARaDAF2 are shown. AF1: Activation
function 1, DBD: DNA-binding domain, LBD: ligand binding domain, AF2: activation function 2. HA-Sirt1 was coimmunoprecipitated with both Myc-PPARa and
Myc-PPARaDAF2.
(E) PGC-1a fails to normalize PPARa/Sirt1-mediated ERRE suppression.
(F) RXR is not necessary for interaction between PPARa and Sirt1. RXR was removed from heart lysates by immunodeprivation. PPARa was then immuno-
precipitated with anti-FLAG antibody.
(G) The effect of an RXRa mutant lacking the DNA-binding domain, RXRa(DN), on PPARa-induced PPRE activation and ERRE suppression.
(H) The effect of full-length RXRa on PPARa-induced PPRE activation and ERRE suppression.
(I) The dosage effect of PPRE reporter on PPARa-induced reporter activity. The indicated amounts of pPPRE-luc reporter plasmids were transfected together
with PPARa and RXRa expression vectors.
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Figure 7. Involvement of PPARa/Sirt1-
Mediated ERRE Suppression in Pressure
Overload (PO)-Induced Cardiac Hyper-
trophy and Fasting
(A and B) After 4 weeks of TAC, ChIP assays were
performed with anti-Sirt1, anti-PPARa, and anti-
histone H3 acetyl-lysine 9 specific antibodies (A)
or anti-ERRa antibody (B) (N = 4–8). PPARa and
Sirt1 bind to the single hexad motifs of HREs in
response to PO in the heart (A), whereas the
occupancy of ERRa on the ERRE decreases (B).
(B) The control region corresponds with Pgc1a
(137 to 0). The number above the control IgG
column represents raw data of the copy number
(31000).
(C) Haploinsufficiencies of PPARa and Sirt1
attenuate PO-induced downregulation of ERR
target gene expression. The expression levels of
the indicated genes were examined by quantita-
tive PCR (N = 4–12).
(D) PPARa/Sirt1-mediated ERRE suppression is
a fasting response. PPARa+/ and Sirt1+/ mice
were subjected to fasting for 24 hr. The expression
levels of the indicated genes were examined (N =
8–20).
(E) The NAD/NADH ratio is increased by 24 hr of
fasting and 4 weeks of TAC (N = 4–8).
(F) Fasting-induced attenuation of systolic func-
tion is mediated by PPARa and Sirt1. Ejection
fraction was measured in PPARa+/ and Sirt1+/
mice after 24 hr of fasting. (N = 18–20).
(G) Hearts were isolated from PPARa+/ and
Sirt1+/ mice and subjected to the Langendorff
perfused heart experiment without any nutrients in
the perfusate. The duration of consecutive beating
was evaluated in each heart (N = 7–9).
(H) PPARa and Sirt1 prolong survival of cultured
cardiac myocytes under glucose-free conditions.
The indicated expression or knockdown was
introduced with adenovirus vectors. Cell viability
was evaluated with trypan blue dye exclusion
following incubation with complete or glucose-
free medium for 72 hr (N = 3). Error bars repre-
sent SEM.
(I) Schematic representations of the regulatory
roles of PPARa, Sirt1, and RXR on the PPRE and
the ERRE during pressure overload and fasting. PPARa shifts the energy source to fatty acids through PPRE activation and minimizes nutritional usage through
ERRE suppression, with the functional binding partners RXR and Sirt1, respectively. PPARa-mediated ERRE suppression is triggered by pressure overload,
which exacerbates cardiac dysfunction due to insufficient energy production.
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PPARa Binding to the Single Hexad Motif Suppresses
Transcription through the ERRE
We here demonstrate molecular mechanisms leading to heart
failure under conditions of mechanical loading that involve(J) The dosage effect of PPRE reporter on PPARa/Sirt1-mediated transcription
expressed as 1.
(K and L) Knockdown of Sirt1 enhances PPARa-induced PPRE activation (K). RXR
(A–F and G–L) Luciferase assays were performed after 1 day (A and B, D and E, an
constructs (N = 6–12). Error bars represent SEM.
(M) Schematic representation of the data shown in this figure. PPARa-induced P
PPARa/Sirt1-mediated ERRE suppression is not affected by RXRa or RXRa(DN) (
complex suppresses transcription through the single hexad unit within the PPRE
Cell Msuppression of the single hexad DNA-binding motif of nuclear
receptors, including that in the ERRE, by the PPARa/Sirt1
complex. Although PPARa acts as a transcriptional activator
on PPRE, it acts as a transcriptional suppressor on the single
hexad motif found in the ERRE. Previously, ChIP-on-chip anal-
yses identified the isolated single hexadmotif of HREs as amajoral regulation. The mean value for activity with PPARa expression alone was
a counteracts PPARa/Sirt1-mediated suppression of PPRE reporter activity (L).
d G–L) and 3 days (C and K) of transduction and transfection with the indicated
PRE activation is enhanced by RXRa but prevented by RXRa(DN). In contrast,
left). When RXR does not cover the half-core site of the PPRE, the PPARa/Sirt1
(right).
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sequences directly bound by PPARa are found not only in the
promoters of 16% of upregulated genes, but also in the
promoters of 18% of downregulated genes in the presence of
a PPARa ligand (van der Meer et al., 2010). These findings
support the possibility that PPARa could negatively regulate
transcription through the single hexad motif. Our results not
only establish the functional significance of the regulation of
the single hexad DNA-binding motif by PPARa, but also show
that it could contribute to mitochondrial dysfunction and even-
tual development of heart failure under conditions of mechanical
loading in the heart.
Dichotomous Functions of PPARa in the Heart
The cardiac role of PPARa is controversial because both PPARa
knockout and PPARa overexpression lead to detrimental
phenotypes in the mouse heart (Finck et al., 2002; Smeets
et al., 2008). The detrimental effect seen in PPARa homozygous
knockout mice may result from impaired PPRE-mediated gene
expression. Our results suggest that PPARa-mediated ERRE
suppression is detrimental to the heart. Since the PPARa/RXR
dimer exhibits a higher affinity for the PPRE than for the single
hexad motif (data not shown), PPRE activation is probably the
primary role of the PPARa/RXR dimer. However, when PPARa
(and Sirt1) is upregulated, the PPARa-Sirt1 complex suppresses
ERRE independently of RXR. Although PPARa-mediated
activation of the PPRE is protective, suppression of ERRE
could be detrimental under stress conditions, such as pressure
overload. Thus, our results provide a potential explanation for
the controversy regarding the cardiac role of PPARa.
Cardiac Role of Sirt1
Sirt1 is required for PPARa-induced regulation of target gene
expression through the PPRE in the liver (Purushotham et al.,
2009), whereas we here show that PPARa and Sirt1 work
together, but that they suppress the ERRE in the heart. The
direction of the transcriptional activity of the PPARa/Sirt1
complex may depend upon DNA-binding sites, requirement of
RXR, cell type, or possibly other unknown mechanisms.
Sirt1 deacetylates ERRa to enhance its DNA-binding in 293
cells (Wilson et al., 2010). Although ERRa was modestly acety-
lated in the Sirt1/ heart, ERRa acetylation was below the
detection limit in wild-type mice both at baseline and after
pressure overload (Figure S4I). Even if Sirt1 deacetylates ERRa
in the heart under pressure overload, its role in mediating
the PPARa/Sirt1-induced suppression of ERRE remains to be
elucidated.
Since suppression of the ERR target genes under pressure
overload conditions is attenuated in Sirt1+/ mice (Figure 7C),
upregulation of endogenous Sirt1 plays an essential role in
mediating suppression of the ERRE. The results of the ChIP
experiments showed that the acetylation status of histone H3
at lysine 9, a specific deacetylation site of Sirt1, located in
flanking regions of the ERRE, was decreased during pressure
overload (Figure 7A). Thus, we speculate that upregulation and
recruitment of Sirt1 through PPARa may inhibit transcription
through the ERRE via histone deacetylation. Alternatively,
Sirt1-mediated recruitment of nuclear corepressors (Picard
et al., 2004) or histone H1 (Vaquero et al., 2004) may contribute608 Cell Metabolism 14, 598–611, November 2, 2011 ª2011 Elsevierto the suppression of ERRE-mediated transcription. Further
investigation is required to elucidate the mechanism by which
the PPARa/Sirt1 complex mediates the suppression.
Potential Effects of PGC1s, ERRs, and theOther Nuclear
Receptors on the ERRE in the Failing Heart
Although PGC-1s are important transcription cofactors for
ERRs, downregulation of PGC-1a was not essential for
PPARa/Sirt1-mediated ERRE suppression (Figures 6E, S3B
and S3C). Knockdown of ERRa does not appear to be sufficient
for inducing recruitment of PPARa to ERREs, whereas upregu-
lated PPARa was recruited to the ERRE (Figure S4C). The level
of PPARa at baseline may not be sufficient to occupy ERREs
in neonatal myocytes. Alternatively, ERRg or ERRb may effec-
tively compensate for the downregulation of ERRa, thereby pre-
venting the recruitment of PPARa to ERREs. Interestingly, each
monomeric unit of the nuclear receptor commonly recognizes
and binds to the single hexad motif, regardless of the overall
receptor assembly (McKenna et al., 2009). Therefore, our finding
that PPARa can bind to the single hexad motif is potentially
applicable to the other nuclear receptors as well. In addition, it
is possible that the PPARa/Sirt1complex suppresses targets of
other nuclear receptors when their DNA-binding sites do not
have a typical PPRE, but are more similar to an isolated single
hexad-like sequence. More investigations are needed in order
to elucidate the role of the PPARa/Sirt1complex in each nuclear
receptor element.
Fasting Responses Involved in the Development
of Cardiomyopathy
Fatty acid catabolism plays a crucial role in maintaining energy
homeostasis during fasting, because fat stored under fed condi-
tions becomes a major source of energy during fasting. Plasma
fatty acids are transported intomitochondria and then converted
to acetyl-CoA through b-oxidation. The acetyl-CoA is consumed
by the tricarboxylic acid (TCA) cycle, which couples to ATP
synthesis through the electron transport chain. Interestingly,
PPARa target genes harboring a PPRE in their promoter regions
are mainly found in the upstream metabolic pathway, including
those involved in fatty acid transport and b-oxidation (Rakhshan-
dehroo et al., 2007). In contrast, ERR target genes are relatively
enriched in the downstream metabolic pathway, including the
TCA cycle and the electron transport chain. Here, we showed
that fasting-induced ERR target gene suppression is attenuated
in PPARa+/ and Sirt1+/ mice (Figure 7D). Thus, although
PPARa facilitates fatty acid utilization through PPRE activation
in the presence of RXR, together with Sirt1, PPARa canminimize
nutritional consumption through ERRE suppression under
starvation conditions (Figure 7I). Since the mitochondrion is the
major energy-generating organelle coupling with nutritional
consumption, and the heart is a major organ consuming energy
and nutrition, the PPARa/Sirt1-mediated restriction of the mito-
chondrial energy metabolism could contribute to survival of cells
and organisms by minimizing the consumption of body-stored
nutrition during starvation. Reduced metabolic rate is believed
to increase survival time in hibernating animals (Staples and
Brown, 2008). Starvation leads to decreased cardiac work,
such as reduced fractional shortening in animals. We found
that the fasting-induced reduction of ejection fraction wasInc.
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cardiac fasting response, which slows down cardiac outputs,
is mediated by PPARa and Sirt1. Our data suggest that
PPARa/Sirt1-mediated ERRE suppression contributes to the
delay of cell death as well as termination of cardiac function
during starvation conditions. The physiological significance of
this mechanism should be further investigated in the heart
in vivo.
Our data support the notion that both PPARa and Sirt1 are
crucial mediators of the fasting response. Importantly, although
such a metabolic adaptation, which minimizes consumption of
nutrition, may provide a survival advantage during fasting, it
could be inappropriate during pressure overload, when the heart
requires energy to maintain contraction against increased
mechanical load. It is currently unknown how PPARa and Sirt1
are upregulated in the failing heart. Reduced nutrition and/or
ATP resulting from high energy expenditure may be sensed as
conditions of reduced nutritional intake in the heart subjected
to pressure overload. Indeed, decreased ATP and creatine
phosphate have been observed in human heart failure patients
(Weiss et al., 2005). In summary, PPARa/Sirt1-mediated down-
regulation of genes regulated by the single hexad unit, including
a subset of ERR target genes, induces mitochondrial dysfunc-
tion, which plays an important role in mediating heart failure.
We propose that normalizing the level of PPARa and Sirt1 to
attenuate ERRE suppression and to achieve physiological
activation of the PPRE by PPARa/RXR may alleviate the
mitochondrial dysfunction commonly observed in heart failure
patients with increasing mechanical loading.EXPERIMENTAL PROCEDURES
Transgenic Mice
The following transgenic mice were used for this study: Cardiac-specific over-
expression of PPARa (Tg-PPARa) or Sirt1 (Tg-Sirt1), Tg-PPARa/Tg-Sirt1,
cardiac-specific Sirt1 heterozygous knockout (Sirt1+/), Tg-PPARa/Sirt1+/,
PPRE-luciferase transgenic (Tg-PPRE-luc), Tg-PPARa/Tg-PPRE-luc, Tg-
Sirt1/Tg-PPRE-luc, Tg-PPARa/Tg-Sirt1/Tg-PPRE-luc, and PPARa heterozy-
gous knockout (PPARa+/) mice. The generation strategies and genetic
backgrounds of these transgenic mice are described in the Supplemental
Information. All procedures involving animals were performed in accordance
with protocols approved by the University of Medicine and Dentistry of
New Jersey.
Transverse Aortic Banding
Micewere anesthetized with pentobarbital sodium. The left chest was opened.
Aortic constriction was performed by ligation of the transverse artery and left
common carotid artery with a 26- or 27-gauge needle.
Isolated Working Mouse Heart Model
Mouse hearts were dissected and perfused with a perfusate [120 mM NaCl,
25 mM NaHCO3, 5.9 mM KCl, 1.2 mM MgCl2, 2.5 mM CaCl2, 0.5 mM EDTA].
The termination time of spontaneous beating was defined as the time at
which +dP/dt of the isolated heart reached less than 400 mmHg/second,
or the beating was paused for more than 0.6 s, whichever came first.
Echocardiography
Micewere anesthetized using avertin (Sigma), and echocardiography was per-
formed to take two-dimension guided M-mode of left ventricular (LV) internal
diameter. LV ejection fraction was calculated as [(LVEDD)3-(LVESD)3]/
(LVEDD)3 3 100. LVEDD; Left ventricular end-diastolic diameter; LVESD: LV
end-systolic diameter.Cell MMicroarray Analyses
Total RNA from the hearts was extracted using the RNeasy Fibrous TissueMini
Kit (QIAGEN). The RNA was used to produce a biotin-labeled cRNA probe for
hybridization to a mouse expression array 430_A2.0 gene chip (Affymetrix,
Santa Clara, CA). The expression signal for each probe-set was obtained by
the RMA (robust multi-chip analysis) method, and the detection was assessed
by the MAS (Microarray Suite) 5.0 method. Expression patterns of regulated
genes were graphically represented in a heat map. The clustering and visual-
ization was carried out by the MultiExperiment Viewer (MeV) (http://www.tm4.
org/mev.html). PPAR and ERR target genes were selected from published
articles. Those target genes overlapping genes whose expression was
significantly changed in Tg-PPARa, Tg-Sirt1, and Tg-PPARa/Tg-Sirt1 bigenic
mice were extracted to generate heat maps.
ATP Synthesis
Mitochondria were freshly isolated from the ventricle using a mitochondria
isolation kit (Sigma, MITOISO1). The isolated mitochondria from 50 mg tissue
weight was suspended with 50 ml storage buffer [10 mM HEPES pH 7.4,
250 mM Sucrose, 2 mM K2HPO4], resulting in around 100 ml final volume of
mitochondrial fraction. ATP production was measured by luminometric assay
using an ATP bioluminescent assay kit (Sigma FL-AA). The ATP assay mix was
diluted with the dilution buffer (1000-fold dilution). The diluted ATP assay mix
(25 ml) was combined with 25 ml substrate buffer [5 mMHEPES pH 7.9, 210mM
Mannitol, 70 mM Sucrose, 10 mM Pyruvate, 10 mM Malate, 4 mM K2HPO4],
and then 1 ml mitochondrial solution was added. After 5 min incubation at
room temperature, the reaction was started by the addition of 1 ml 12.5 mM
ADP. The luminescence was measured by luminometer for 30 s. The mean
value of non-Tg was expressed as 1.
Quantitative RT-PCR
Total RNA was prepared from left ventricles using the RNeasy Fibrous Tissue
Mini Kit (QIAGEN), and then cDNA was generated using M-MLV Reverse
transcriptase (Promega). Real-time RT-PCR was performed using the Maxima
SYBR Green qPCR master mix (Fermentas). Ribosomal RNA (15S) was
used as an internal control. The oligonucleotide primers used to carry out
the PCRs are described in the Supplemental Information.
Luciferase Assay
Luciferase activity was measured with a luciferase assay system (Promega).
Dissected ventricles from Tg-PPRE-luc transgenic mice were weighed and
lysed with 300 ml Reporter lysis buffer (Promega) per 50mg tissue weight using
a Polytron homogenizer. In cultured mycocytes, reporter and expression plas-
mids were transfected into neonatal primary myocytes (12-well plate) using
LipofectAmine 2000 (Invitrogen). The amounts of expression vectors trans-
fected into cells per well were 0.3 mg PPARa, 0.3 mg Myc-PPARa, 0.3 mg
PPARaDAF2, 0.01 and 0.1 mg Sirt1, 0.1 and 0.3 mg RXRa, 0.6 mg RXRa(DN),
0.3 mg Myc-VP16-ERRa, and 0.3 mg luciferase reporter plasmids. The total
amount of plasmid vectors was kept constant (1 to 1.3 mg) using the control
vector. Alternatively, after overnight culture, adenovirus vectors carrying
Sirt1 (0.1 to 3 moi), PPARa (5 moi), siRNA-Sirt1 (10 moi), siRNA-ERRa
(10 moi) or siRNA-scramble (10 moi) were transduced. The total moi of adeno-
virus was kept constant using lacZ virus. Cells were lysed with 100 ml reporter
lysis buffer after 1–4 days of transfection or transduction. For both tissue and
cultured cell lysates, the luminescence was normalized by protein content.
Immunoblotting
Mouse heart tissue samples (10–30 mg) were analyzed by western blot using
antibodies against PPARa (Cayman), Sirt1 (Millipore), RXR (Santa Cruz),
ERRa (Millipore), histone H3 (Cell Signaling Technology), acetylated-lysine
(Cell Signaling Technology), tubulin (Sigma), and GAPDH (Sigma).
Double-Stranded DNA Pull-Down Assay
Mouse heart tissue samples were weighed and lysed with 0.5 ml lysis buffer
containing 10 mM Tris (pH 8), 3 mM CaCl2, 1% NP-40, 320 mM Sucrose,
0.1 mM EDTA, 1 mM DTT, and Protease Inhibitor Cocktail (Sigma) per
50 mg tissue weight. The heart lysate (50 ml) was diluted with an equal volume
of 2 3 pull-down buffer (20 mM HEPES [pH 8], 100 mM KCl, 5 mM MgCl2,
2 mM EDTA, 2 mM DTT, and 0.2% NP-40. Biotin-labeled double-strandedetabolism 14, 598–611, November 2, 2011 ª2011 Elsevier Inc. 609
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to the lysate and rotated at 4C for 2 hr. The streptavidin-agarose was washed
with 1 ml 13 pull-down buffer three times. Biotin labeled sense and nonbiotin-
labeled antisense oligonucleotides were purchased from IDT (Integrated DNA
Technologies) and annealed using a thermal cycler to generate biotin labeled
double-stranded DNA.
Chromatin Immunoprecipitation Assay
The ChIP assays were performed using the SimpleChIP Enzymatic Chromatin
IP kit (Cell Signaling Technology #9002) with several modifications. Briefly,
formaldehyde-crosslinked chromatin solution was prepared from ventricles
corresponding to 200–1000 mg (from 3–10 mice). The chromatin solution
(1–5 mg DNA) was used for each immunoprecipitation with 1 mg antibodies
and 15 ml protein G-agarose beads. Collected chromatin fragments were
measured by quantitative PCR with oligonucleotide primers described in the
Supplemental Information.
Statistical Methods and Error Bars
Statistical comparisons were made using the Student’s t test. p < 0.05 was
defined as statistically significant and indicated by a filled asterisk. p > 0.05
was indicated by NS. All error bars represent SEM.
ACCESSION NUMBERS
GSE33101 is the accession number of the microarray data, which is available
on the Gene Expression Omnibus website (http://www.ncbi.nlm.nih.gov/geo).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.cmet.2011.10.001.
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